Xcout Intel
Immunitas Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Immunitas Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Immunitas Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Immunitas Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
Immunitas Therapeutics, Inc. at a glance
Immunitas Therapeutics, Inc. is a biotechnology company headquartered in United States, founded in 2019. Its most recent funding round raised $29.1M in August 2021. Xcout tracks 4 named people at Immunitas Therapeutics, Inc., including Amanda Wagner (CEO).
Immunitas Therapeutics, Inc. leadership
- Amanda WagnerCEO
- Lynette HerschaChief Operating Officer
- Annalisa D’AndreaChief Scientific Officer
- James WooldridgeChief Medical Officer
Immunitas Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $29.1M | — | |
| Series B | $58M | 1 named | |
| Series A | $65M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Immunitas Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Immunitas Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
Similar biotechnology company
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, with an additional office in Belgium. The company focuses on discovering and developing novel immuno-oncology therapeutics for cancer treatment.
Similar biotechnology company
Mythic Therapeutics, Inc. is a biotechnology research company headquartered in Waltham, Massachusetts. The company is dedicated to developing a proprietary platform to enhance the effectiveness of antibody-drug conjugates and other antibody-based therapeutics.
Similar biotechnology company
Boston Immune Technologies and Therapeutics, Inc. (BITT) is a company headquartered in Winchester, Massachusetts, that specializes in the development of cancer treatments and therapeutics.
Similar biotechnology company
Korsana Biosciences is a private biotechnology research company founded in 2024 and headquartered in Waltham, Massachusetts.
Similar biotechnology company
TigaTx is a Boston-based biotechnology company founded in 2018 that is developing a pipeline of therapies targeting various cancer types and infectious diseases.
Life Sciences
Ypsilon Therapeutics is a biotechnology research company founded in 2024 and headquartered in Waltham, Massachusetts, that develops T cell receptor mimics against tumor antigens.
Similar biotechnology company
Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Similar biotechnology company
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Similar biotechnology company
ImmunOs Therapeutics AG is a biotechnology company that develops treatments for cancer and inflammatory diseases by harnessing the human immune system. The company focuses on immuno-oncology and autoimmune therapies through a dedicated drug pipeline.
Similar biotechnology company
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Biotech
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Immunitas Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Immunitas Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →